We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 413

In Re: Aqua Products, Inc
  • Winston & Strawn LLP
  • USA
  • July 20 2016

Aqua Products, Inc. (patent owner) appealed from a written decision of the Patent Trial and Appeal Board (PTAB) in an inter partes review (IPR) of a


TLI Communications LLC v. AV Automotive, L.L.C
  • Winston & Strawn LLP
  • USA
  • July 20 2016

TLI Communications appealed the Eastern District of Virginia’s decision that its patent failed to claim patent-eligible subject matter under 35 U.S.C


Genzyme Therapeutic Products v. Biomarin Pharmaceutical
  • Winston & Strawn LLP
  • USA
  • July 20 2016

The patentee appealed two inter partes review (IPR) decisions of the Patent Trial and Appeal Board (PTAB), arguing that by relying on facts and legal


Bascom Global Internet Services, Inc. v. AT&T Mobility LLC
  • Winston & Strawn LLP
  • USA
  • July 20 2016

The patentee appealed the district court’s grant of the accused infringer’s motion to dismiss under Fed. R. Civ. P. 12(b)(6), finding that the claims


SAS Institute, Inc. v. ComplementSoft, LLC
  • Winston & Strawn LLP
  • USA
  • July 20 2016

On SAS’s petition for inter partes review (IPR), the Patent Trial and Appeal Board (PTAB) instituted a review on some but not all of the challenged


Intendis GMBH, et al. v. Glenmark Pharmaceuticals, Inc., et al
  • Winston & Strawn LLP
  • USA
  • July 20 2016

In a Hatch-Waxman case, the district court held that the alleged infringer’s Abbreviated New Drug Application (ANDA) product, a topical gel for the


Supreme Court Confirms Institution of Inter Partes Review Is Unreviewable, Upholds “Broadest Reasonable Interpretation” of Patent Claims
  • Winston & Strawn LLP
  • USA
  • June 22 2016

This week, in a closely watched case, the Supreme Court affirmed the Federal Circuit on two questions regarding the inter partes reviews before the


Supreme Court Changes Standard for Obtaining Enhanced Damages in Patent Cases
  • Winston & Strawn LLP
  • USA
  • June 14 2016

In a pair of closely watched patent cases, the Supreme Court yesterday lowered the requirements for proving enhanced damages under Section 284 of the


Rembrandt Vision Techs, L.P. v. Johnson & Johnson Vision Care
  • Winston & Strawn LLP
  • USA
  • May 12 2016

The patent owner appealed the district court’s denial of a Rule 60(b)(3) motion for a new trial following a jury’s verdict that the plaintiff had


Genetic Technologies Limited v. Merial LLC
  • Winston & Strawn LLP
  • USA
  • May 12 2016

The patentee sued for infringement of a patent related to methods of analyzing sequences of DNA within an individual’s genome. Specifically, the